结直肠息肉患者一级亲属的结直肠癌风险:瑞典全国病例对照研究
该研究基于瑞典全国病例对照数据,评估结直肠息肉患者一级亲属的结直肠癌风险。调整结直肠癌家族史等因素后,一级亲属有息肉者结直肠癌风险升高(OR 1.40,95%CI 1.35-1.45),且风险随息肉亲属数量增加和诊断年龄降低而增强,早发性结直肠癌关联尤强。
要点
- 结直肠息肉患者一级亲属的结直肠癌风险升高,OR 1.40(95%CI 1.35-1.45)。
- 风险随一级亲属息肉数量增加和诊断年龄降低而增强。
- 早发性结直肠癌(<50岁)且≥2个一级亲属有息肉者OR 3.34。
核心结论
- 调整结直肠癌家族史后,结直肠息肉患者的一级亲属结直肠癌风险仍升高,尤其早发性结直肠癌。
- 可考虑对息肉患者一级亲属早期筛查结直肠癌。
研究设计与样本
- 病例对照研究,纳入68 060例结直肠癌患者和333 753名匹配对照。
- 数据来自瑞典多代登记和ESPRESSO组织病理学队列。
主要发现
- 一级亲属有息肉者在病例中占8.4%(5742/68 060),对照中占5.7%(18 860/333 753)。
- 结直肠癌风险OR 1.40(95%CI 1.35-1.45),范围从增生性息肉1.23到管状绒毛状腺瘤1.44。
- ≥2个一级亲属有息肉OR 1.70(95%CI 1.52-1.90),息肉诊断年龄<50岁OR 1.77(95%CI 1.57-1.99)。
- 早发性结直肠癌(<50岁)且≥2个一级亲属有息肉OR 3.34(95%CI 2.05-5.43)。
- 联合分析:≥2个一级亲属有息肉但无结直肠癌OR 1.79(95%CI 1.52-2.10),1个一级亲属有结直肠癌但无息肉OR 1.70(95%CI 1.65-1.76),≥2个一级亲属同时有息肉和结直肠癌OR 5.00(95%CI 3.77-6.63)。
关键数值与推荐
- 基于2018年瑞典全国结直肠癌发病率,60-64岁男性有和无息肉家族史的结肠癌绝对风险分别为94.3/10万和67.9/10万。
- 同年龄段女性有和无息肉家族史的结肠癌绝对风险分别为89.1/10万和64.1/10万。
临床怎么用
- 对结直肠息肉患者的一级亲属,尤其多个亲属有息肉或息肉诊断年龄早者,可考虑早期结直肠癌筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the risk of colorectal cancer (CRC) in first degree relatives (parents and full siblings) of patients with precursor lesions (polyps) for CRC. DESIGN: Case-control study. SETTING: Linkage to the multi-generation register and gastrointestinal ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden) histopathology cohort in Sweden. PARTICIPANTS: 68 060 patients with CRC and 333 753 matched controls. MAIN OUTCOME MEASURES: Multivariable adjusted odds ratios of CRC according to the number of first degree relatives with a colorectal polyp and the histology of polyps and age at diagnosis in first degree relatives. Subgroup analysis was also performed according to age at CRC diagnosis and evaluated the joint association of family history of colorectal polyps and family history of CRC. RESULTS: After adjusting for family history of CRC and other covariates, having a first degree relative with a colorectal polyp (8.4% (5742/68 060) in cases and 5.7% (18 860/333 753) in controls) was associated with a higher risk of CRC (odds ratio 1.40, 95% confidence interval 1.35 to 1.45). The odds ratios ranged from 1.23 for those with hyperplastic polyps to 1.44 for those with tubulovillous adenomas. To better put this risk in perspective, the age specific absolute risk of colon and rectal cancers was estimated according to family history of polyps based on the 2018 national CRC incidence in Sweden. For example, the absolute risk of colon cancer in individuals aged 60-64 years with and without a family history of colorectal polyp was, respectively, 94.3 and 67.9 per 100 000 for men and 89.1 and 64.1 per 100 000 for women. The association between family history of polyps and CRC risk was strengthened by the increasing number of first degree relatives with polyps (≥2 first degree relatives: 1.70, 1.52 to 1.90, P<0.001 for trend) and decreasing age at polyp diagnosis (<50 years: 1.77, 1.57 to 1.99, P<0.001 for trend). A particularly strong association was found for early onset CRC diagnosed before age 50 years (≥2 first degree relatives: 3.34, 2.05 to 5.43, P=0.002 for heterogeneity by age of CRC diagnosis). In the joint analysis, the odds ratio of CRC for individuals with two or more first degree relatives with polyps but no CRC was 1.79 (1.52 to 2.10), with one first degree relative with CRC but no polyps was 1.70 (1.65 to 1.76), and with two or more first degree relatives with both polyps and CRC was 5.00 (3.77 to 6.63) (P<0.001 for interaction). CONCLUSIONS: After adjusting for family history of CRC, the siblings and children of patients with colorectal polyps are still at higher risk of CRC, particularly early onset CRC. Early screening for CRC might be considered for first degree relatives of patients with polyps.
引用
- Song M, Emilsson L, Roelstraete B, et al. Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden. BMJ. 2021. PMID: 33947661. doi:10.1136/bmj.n877
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。